SGI-110 in Combination With an Allogeneic Colon Cancer Cell Vaccine (GVAX) and Cyclophosphamide (CY) in Metastatic Colorectal Cancer (mCRC)
Clinical trial NCT01966289 · COMPLETED
Trial details
- NCT number
- NCT01966289
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-14
- Primary completion
- 2020-06-06
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.